{"id":60674,"date":"2025-01-24T01:02:45","date_gmt":"2025-01-24T00:02:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/"},"modified":"2025-01-24T01:02:45","modified_gmt":"2025-01-24T00:02:45","slug":"aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/","title":{"rendered":"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details"},"content":{"rendered":"
\n

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025.<\/p>\n

<\/a>
<\/a><\/p>\n

\nAs previously announced, Aptar will hold a conference call on Friday, February 7, 2025 at 8:00 a.m. Central Time to discuss the Company\u2019s fourth quarter and year-end results for 2024. The call will last approximately one hour. Interested parties are invited to listen to a live webcast by visiting the Investors page at www.aptar.com<\/a>. Replay of the conference call can also be accessed for a limited time on the Investors page of the website.<\/p>\n

\nAnnual Meeting<\/b><\/p>\n

\nThe Board also announced that the 2025 Annual Meeting of Stockholders will be held virtually on May 7, 2025, at 9:00 a.m. Central Time. The record date for stockholders entitled to vote at the meeting is March 14, 2025. More details regarding accessing the meeting will be shared as we get closer to the event.<\/p>\n

\nAbout Aptar<\/b><\/p>\n

\nAptar is a global leader in drug and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world\u2019s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com<\/a>.<\/p>\n

\nThis press release contains forward-looking statements. Expressions or future or conditional verbs such as \u201cwill\u201d are intended to identify such forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on our beliefs as well as assumptions made by and information currently available to us. Accordingly, our actual results may differ materially from those expressed or implied in such forward-looking statements due to known or unknown risks and uncertainties that exist in our operations and business environment including, but not limited to: the successful integration of acquisitions; the regulatory environment; and competition, including technological advances. For additional information on these and other risks and uncertainties, please see our filings with the Securities and Exchange Commission, including the discussion under \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations\u201d in our Form 10-Ks and Form 10-Qs. We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.<\/i><\/p>\n

Contacts<\/b> <\/p>\n

\nInvestor Relations Contact<\/span>:<\/b>
Mary Skafidas
\n
Mary.skafidas@aptar.com<\/a>
+1 347-351-6407
\n<\/p>\n

\nMedia Contact:<\/span><\/b>
Katie Reardon
\n
katie.reardon@aptar.com<\/a>
+1 815-479-5671<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025. As previously announced, Aptar will … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-60674","6":"format-standard","7":"category-industry"},"yoast_head":"\nAptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025. As previously announced, Aptar will ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-24T00:02:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250123941903\/en\/685330\/22\/aptar_logo_rgb.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details\",\"datePublished\":\"2025-01-24T00:02:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/\"},\"wordCount\":487,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123941903\\\/en\\\/685330\\\/22\\\/aptar_logo_rgb.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/\",\"name\":\"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123941903\\\/en\\\/685330\\\/22\\\/aptar_logo_rgb.jpg\",\"datePublished\":\"2025-01-24T00:02:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123941903\\\/en\\\/685330\\\/22\\\/aptar_logo_rgb.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250123941903\\\/en\\\/685330\\\/22\\\/aptar_logo_rgb.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/","og_locale":"en_US","og_type":"article","og_title":"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details - Pharma Trend","og_description":"CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–AptarGroup, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that the Board declared a quarterly cash dividend of $0.45 per share. The payment date is February 26, 2025, to stockholders of record as of February 5, 2025. As previously announced, Aptar will ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/","og_site_name":"Pharma Trend","article_published_time":"2025-01-24T00:02:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250123941903\/en\/685330\/22\/aptar_logo_rgb.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details","datePublished":"2025-01-24T00:02:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/"},"wordCount":487,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250123941903\/en\/685330\/22\/aptar_logo_rgb.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/","url":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/","name":"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250123941903\/en\/685330\/22\/aptar_logo_rgb.jpg","datePublished":"2025-01-24T00:02:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250123941903\/en\/685330\/22\/aptar_logo_rgb.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250123941903\/en\/685330\/22\/aptar_logo_rgb.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/aptar-declares-quarterly-dividend-and-announces-2025-annual-meeting-details\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Aptar Declares Quarterly Dividend and Announces 2025 Annual Meeting Details"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=60674"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/60674\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=60674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=60674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=60674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}